1) It has been proposed and shown that the actual removal of atherosclerotic material debulks the artery which results in a larger and angiographically smoother residual luminal diameter with or without accompanying balloon angioplasty.2-6) This in turn has been suggested as translating into a reduction of the 6 month restenosis rate.7-14) However, the bulk of the accumulated data has shown that DCA has a higher immediate complication rate as compared to balloon angioplasty. It has been suggested that the immediate success rate of PTCA and DCA are comparable.1, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In this retrospective study we tested the hypothesis that atherectomy leads to a higher success rate with a comparable complication rate and lower restenosis rate in vessels>3mm in diameter, as compared to balloon angioplasty.
MATERIALS AND METHODS

Study population:
104 and 96 consecutive patients who had DCA and PTCA, respectively, from the periods immediately following and preceding the initiation of the DCA procedure at Millard Fillmore Hospital in 1992 were included in this study as it was felt that once DCA was used there was an interventionist bias towards performing DCA in larger vessels. DCA and PTCA patients were chosen from the interval January 1992 to May 1994 and January 1990 to January 1992, respectively. Forty-six DCA and 54 PTCA cases, which were performed between August 1995 (the date when we started DCA procedures at Dokuz Eylul University Medical Faculty Hospital) and August 1996 and January 1994 and August 1995 were also added to this population. Only CCS class 3 and 4 patients were included in the study. No emergency case was included in the study cohort.
The study cohort included proximal and mid LAD and RCA stenoses in vessels>3mm in diameter based on the most normal adjacent segment measurements proximal or distal to the target lesion. Each target lesion was entered as a separate case. Patients with more than 1 target lesion in the indicated segments of an artery were excluded. The ostial lesions, distal segment lesions, branch lesions and all circumflex lesions were excluded. Restenosis, bail out atherectomy, graft procedures, and lesions in which a<7 Fr device was used were also excluded. Procedures:
All patients received aspirin and a calcium channel blocker (usually diltiazem 60mg) before the procedures. The procedures were performed via the usual femoral approach and all the patients were heparinized with a bolus of 10,000 units of heparin. The activated clotting time (ACT) was kept between 300-350 seconds throughout the procedure by giving additional boluses of heparin when needed. Aspirin was continued as the only antiaggregant therapy in all cases without any major complications requiring any kind of bail-out procedure. Cardiac enzymes were measured routinely for all patients during their hospital stay and before discharge. Definitions: Initial success was defined as a greater than 20% gain in the luminal diameter or a reduction of the stenosis rate below 50% in the absence of major in-hospital complications defined as death, emergency coronary artery bypass grafting (ECABG) and Q-wave myocardial infarction (Q MI).
Major acute complications were defined as major in-hospital complications plus acute occlusion, re-do and cerebrovascular accident.
Re-do was defined as repeat PTCA or DCA of the target lesion within 24 hours after the procedure due to either acute occlusion or continuing ischemia secondary to suboptimal initial result.
Non-Q-wave myocardial infarction (non-Q MI) was defined as a greater than 4-fold increase of the level of cardiac creatinine phosphokinase (CPK-MB) above the upper limit of normal in the absence of newly developed pathologic Q cases (4 major in-hospital complications and 20 significant residual stenosis) failed to achieve initial success (defined as reduction of the percent diameter stenosis below 50% and/or net gain of at least 20% and absence of major in-hospital complications consisting of death, cerebrovascular accident, Q wave MI and ECABG). The initial success rates were similar in both groups (91% vs 84%). There were 87 dissections in the DCA arm and 63 in the PTCA group (type A to F).25) Twenty seven DCA and 31 PTCA cases required perfusion balloon inflations due to C-F type dissections. However, post-DCA balloon dilatations were performed in 55 DCA cases either to further reduce the residual stenosis or further smooth the luminal borders while two simultaneous balloon inflations (4 mm+2mm) were performed in a PTCA case to match the 6mm artery size.
The complications are listed in Table IV . Re-do cases were significantly higher in the DCA group (p<0.05). The difference between the DCA and PTCA groups in terms of major in-hospital complication rates were not statistically significant (2.7% vs 4.7%). However when we add acute occlusion and re-do as major acute complications the difference reaches statistical significance (12% vs 6%, p<0.05). Significant dissections requiring perfusion balloon occurred equally in both groups (18% vs 20.5%).
When we look closer at the distribution of the complications we see that 3 PTCA patients with acute occlusions received intracoronary urokinase treatment. One resolved with non-Q MI while another resolved in a Q-vave MI. The third was redone successfully by using various balloons, including a perfusion balloon. 1 Two femoral pseudoaneurysms; 2Requiring transfusion; 3More than one major complication was observed in some patients; ns*=non-significant.
Three patients from Izmir received intracoronary streptokinase. Two patients resolved with non-Q MI and the third one was bailed out by successful stent implantation without any other complication. Three patients with severe dissections from Buffalo were sent for ECABG.
Six DCA patients from Buffalo developed acute occlusion. Five received intracoronary urokinase which resulted in 2 Q and 2 non-Q MI while two patients were redone developing a non-Q MI. Three patients were sent to ECABG and three patients in Buffalo were redone by combined repeat DCA and PTCA due to severe dissections and continuing chest pain. Two of these patients developed non-Q MI (one from each group).
Three DCA patients from Izmir developed acute occlusion. One of these patients received intracoronary streptokinase and resolved with a non-Q MI. Two were bailed out by stent implantation which resulted in one Q and one non-Q MI. One patient was sent to ECABG due to massive dissection of LAD involving all proximal and mid segments of the artery. The patient developed non-Q MI. There were two more patients with type D dissection and continuing chest pain who were successfully stented.
In addition, 3 PTCA and % DCA patients from Buffalo and 3 DCA and one PTCA patient from Izmir developed cardiac enzyme elevations which met the criteria for non-Q MI. There were two cases of pseudoaneurysm formation and one groin bleeding requiring blood transfusion following DCA in the Buffalo group.
In 49 (33%) of the patients in the DCA group zero or a negative residual stenosis rate was achieved while in only 8 (5%) of the angioplasty group zero angiography and repeat procedures. The cause of symptoms and/or positive stress test were lesions other than the target lesion for which the patients were included in the study cohort in a fairly large number of patients. We only considered those patients with angiographically proven restenosis of the index lesion as true restenotic cases. The angiographically proven restenosis rate within 6 months after the procedure was 18% for the DCA group and 28% for the PTCA group ( Figure 2) . However, the difference again failed to reach statistical significance.
DISCUSSION
The principle finding of this study was that DCA achieved a greater reduction in the severity of stenosis than was achieved in a similar population using conventional balloon angioplasty in vessels larger than 3mm in diameter. This is consistent with the findings in CAVEAT and CCAT studies and the data reported by Kimball B.P. et al. 1, 14, 17) This increased success in initial gain was obtained by paying the price of a tendency toward a higher major in-hospital complication and major acute complication rate. When we examine Table IV we see that re-dos are higher in the DCA group (1.3% vs 6%; p<0.05) with acute occlusion and non-Q and Q MIs being higher in the DCA group without reaching statistical significance (4% vs 6%, 4.3%vs 10.6% and 0.7% vs 2%, respectively). We believe that this difference was principally due to a higher rate of distal embolization and nose-cone traumatization of healthy vessel segments, which are inherent complications of DCA. We believe that unlike the CCAT and CAVEAT study groups the operator experience was not a factor in creating these higher rates of complications in our study. Higher groin and bleeding complications are most likely due to the usage of large bore sheaths (larger than 9.5 F). This is also consistent with the findings of previous studies including the CA-VEAT study. 1, [15] [16] [17] [18] [19] [20] [21] [22] [23] [26] [27] Our data showed equal significant dissection rates while Rowe et al. reported almost three times as many dissections in their PTCA group as compared to the DCA group which included a wide range of arteries and segments.23) This study showed a lower 6-month restenosis rate which was thought to be a translation of better initial results in contradiction to the findings of some previous major studies. 1, 15, [21] [22] [23] In fact, the rate of clinical restenosis was estimated to be approximately 35% for both the DCA and PTCA groups in the CAVEAT study which is consistent with 28% clinical restenosis rate in the PTCA group in this study, while the DCA group had an 18% restenosis rate. Considering the fact that the interventionists in the CAVEAT study were not aggressive enough to achieve a better initial result (their residual stenosis rate was 29% as compared to our residual stenosis rate of 11%) and based on the fact that a bigger residual diameter translates into less restenosis we can conclude that DCA can be an effective tool for reducing the restenosis rate provided the interventionists are as aggressive as they need to be.
We can speculate that the fact that only vessels larger than 3mm in diameter were included in our study seemed to have very little impact if any on the restenosis rate, since the restenosis rate for the PTCA group was comparable to the CAVEAT group which included a considerable number of smaller vessels as well.
Despite the more aggressive approach to our patient groups, the major inhospital complication rates were almost identical with those of the CAVEAT groups. This suggests that further reduction in complication rates might be possible with adherence to careful and meticulous procedure techniques and increasing experience.
There are two multicenter studies (BOAT and OARS) which are still unpublished to test this hypothesis.28,29) The preliminary results are confirmatory (unpublished data). Study limitations: This is a retrospective case control study which carries the inherent limitations of selection bias both before the procedure at the stage of decision making and at the inclusion of the cases to this cohort. The patients recruited in the United States were chosen mostly from the era before the introduction of elective stents while DCA procedures were virtually unknown in the Turkish hospital before June 1995. The stents were available since 1994 in the Turkish hospital which might have caused serious selection bias for the large sized vessels which were also suitable for stenting.
However, both centers perform large numbers of DCA procedures and have become highly experienced in this technique. This might have resulted in better atherectomy results as compared to the combined results of the numerous centers with small DCA volumes who participated in the CCAT and CAVEAT studies.
The angiographic variables were basically measured by hand calipers as it was felt that the routine QCA measurements were not performed in a standardized fashion although QCA data were available. Clinical significance: Rational and appropriate case selection involves operator judgement regarding the segments involved, lesion type, selection of proper device size and performance in regard to individualized, case specific anatomic features. We think that at least in large sized proximal and mid coronary artery segments DCA with 7Fr or larger devices is a safe, reliable alternative to PTCA and results in better initial results along with lower clinical restenosis rates.
